ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,296.00
-0.41%
S&P ASX All Technology
3,854.60
-0.04%
Brent Oil
74.135
0.00%
US Dollar vs AUD
1.57257
-0.09%
Bitcoin
100,926.72
-0.52%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Orange. (ORA) Share Price

Orange.

Orange. (ORA)

Ora Technology Plc
Orora Ltd
Ormat Technologies Inc
Ordina NV
Aura Minerals Inc
9.61
0.048
(0.50%)
Closed 15 December 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
9.61
Bid
9.606
Offer
9.65
Volume
5,332,156
9.49 Day's Range 9.624
9.192 52 Week Range 11.37
Market Cap
25.544B
Previous Close
9.562
Open
9.554
Last Trade
10000
@
9.61
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
6,996,031
Shares Outstanding
2,658,091,428
Dividend Yield
7.49%
PE Ratio
10.47
Earnings Per Share (EPS)
0.92
Revenue
45.03B
Net Profit
2.44B

About Orange.

Sector
Communications Services, Nec
Industry
Communications
Website
www.orange.com
Headquarters
Issy-les-moulineaux, Hauts-de-seine, Fra
Founded
1996
Orange. is listed in the Communications Services sector of the Euronext with ticker ORA. The last closing price for Orange was 9.56 €. Over the last year, Orange shares have traded in a share price range of 9.192 € to 11.37 €.

Orange currently has 2,658,091,428 shares in issue. The market capitalisation of Orange is 25.42 € billion. Orange has a price to earnings ratio (PE ratio) of 10.47.

Ask ADVFN Intelligence (AI)

ORA Latest News

More News

Total number of shares and voting rights at November 30, 2024

Total number of shares and voting rights at November 30, 2024 9 December 2024 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French...

10 December 2024
UK Regulatory

Nombre d'actions et de droits de vote au 30 novembre 2024

Nombre d'actions et de droits de vote au 30 novembre 2024 9 décembre 2024 Orange : Information relative au nombre total d’actions et de droits de vote prévue par l’article L. 233-8 II du...

10 December 2024
UK Regulatory

Communiqué : Orange conteste les mesures prises par le PNF dans un contentieux sur la TVA pour 2017-2019

Communiqué : Orange conteste les mesures prises par le PNF dans un contentieux sur la TVA pour 2017-2019 Communiqué de presseParis, le 15 novembre 2024 Orange conteste les mesures prises par le...

16 November 2024
UK Regulatory

Press release: Orange contests the measures taken by the PNF concerning a VAT allocation dispute for 2017-2019

Press release: Orange contests the measures taken by the PNF concerning a VAT allocation dispute for 2017-2019 Press releaseParis, 15 November 2024 Orange contests the measures taken by the PNF...

16 November 2024
UK Regulatory

Total number of shares and voting rights at October 31, 2024

Total number of shares and voting rights at October 31, 2024 12 November 2024 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French...

13 November 2024
UK Regulatory

Nombre d'actions et de droits de vote au 31 octobre 2024

Nombre d'actions et de droits de vote au 31 octobre 2024 12 novembre 2024 Orange : Information relative au nombre total d’actions et de droits de vote prévue par l’article L. 233-8 II du...

13 November 2024
UK Regulatory

Communiqué - Orange : Bons résultats au 3ème trimestre, objectifs financiers 2024 confirmés

Communiqué - Orange : Bons résultats au 3ème trimestre, objectifs financiers 2024 confirmés Communiqué de presseParis, le 24 octobre 2024 Information financière au 30 septembre 2024 Bons...

24 October 2024
UK Regulatory

Press release - Orange: Strong third-quarter results, 2024 financial targets confirmed 

Press release - Orange: Strong third-quarter results, 2024 financial targets confirmed  Press release Paris, 24 October 2024 Financial results at 30 September 2024 Strong third-quarter results...

24 October 2024
UK Regulatory

Press release: Orange completed its voluntary delisting from the NYSE and filed a certification of deregistration with the SEC. Orange maintains a level 1 ADR program

Press release: Orange completed its voluntary delisting from the NYSE and filed a certification of deregistration with the SEC. Orange maintains a level 1 ADR program Press releaseParis, 18...

19 October 2024
UK Regulatory

Communiqué: Orange a finalisé son retrait volontaire du NYSE et a déposé un certificat de désenregistrement auprès de la SEC. Orange maintient un programme ADR de niveau 1.

Communiqué: Orange a finalisé son retrait volontaire du NYSE et a déposé un certificat de désenregistrement auprès de la SEC. Orange maintient un programme ADR de niveau 1. Communiqué de...

19 October 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-1.233299075039.739.8549.4954523669.64955814DE
4-0.14-1.43589743599.7510.179.39269493489.82677471DE
12-1.18-10.936051899910.7910.929.392699603110.0349282DE
260.11.051524710839.5110.9759.192632807810.03995872DE
52-1.524-13.687803125611.13411.379.192598919110.30634158DE
1560.6467.206604194568.96411.9388.926645132710.41378552DE
260-3.87-28.709198813113.4813.5458.632703854410.42646807DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMARMare Nostrum
0.41 €
(51.85%)
21.31k
MLUMGUmalis Group
1.54 €
(45.28%)
1.7k
ALTROTronic s Microsystems
5.00 €
(44.51%)
167
IPHInnate Pharma
1.90 €
(22.58%)
579.44k
ALBOOBOOSTHEAT
0.209 €
(21.87%)
15.75k
MLGEQGentlemen S Equity SA
0.008 €
(-33.33%)
34k
MLIMLImalliance
0.346 €
(-23.11%)
10.58k
ALNEVNeovacs
1.60 €
(-17.52%)
2.38k
ALGTRGroupe Tera SA
2.04 €
(-15.00%)
100
NXFILNX Filtration NV
3.53 €
(-14.11%)
745.94k
ATOAtos SE
0.0023 €
(-11.54%)
4.75B
BCPBanco Comercial Portugues SA
0.4458 €
(1.16%)
48.07M
VIVVivendi SE
8.30 €
(-2.81%)
27.05M
ALHPIHopium SA
0.008 €
(0.00%)
23.6M
ALCYBCybergun
0.0001 €
(0.00%)
20.46M

Discussion

View Full Feed
LTListener LTListener 4 minutes ago
Patent protection would be another point of clarity on all assets…

I think others here have stated the company said patent progress is not holding anything up…

But who knows. Some companies put that detail on their webpage and continually update progress
RSPI
100lbStriper 100lbStriper 5 minutes ago
poltergeist......... https://www.google.com/search?q=there+here+poltergeist+gif&oq=there+here&gs_lcrp=EgZjaHJvbWUqBwgHEAAYgAQyCQgAEEUYORiABDIKCAEQLhiABBjlBDIHCAIQABiABDIHCAMQABiABDIHCAQQABiABDIHCAUQABiABDIHCAYQABiABDIHCAcQABiABDIHCAgQABiABDIMCAkQLhgKGNQCGIAE0gEKMTQzMzZqMGoxNagCCLACAQ&sourceid=chrom
al44 al44 5 minutes ago
CNN and MSNBC belong in the garbage heap of failures.

................al
travayl travayl 6 minutes ago
Still no posting as of Saturday, 1:30 pm. But thanks for contacting the company.
MRKR
familyof5 familyof5 6 minutes ago
Enjoy your weekend NoMoDo! And thanks again for an engaging in fruitful dialog!
HMBL
NY1972 NY1972 6 minutes ago
The combination of p95HER2.CAR T cells and HER2?x?CD3 bispecific antibodies lead to a complete regression in three HER2-positive, patient-derived mouse xenografts tumor models
https://pmc.ncbi.nlm.nih.gov/articles/PMC11574131/
FATE
al44 al44 7 minutes ago
Hey bbotcs-

Yeah. You got that right.

.............al
JAB65 JAB65 7 minutes ago
You also have a tendency to repeat yourself. You've stated all of the facts several times. we get it.
The way you lay it out is just one possibility. Your opinions are no more valid than anybody else's
Short is sweet. Just saying. Enough done with this topic.
TGLO
100lbStriper 100lbStriper 7 minutes ago
all is still good, no worries.
NLST
al44 al44 7 minutes ago
I have just read that Texas is going to buy a lot of it and donate it back to Trump. Not the bee.

..........................al
NorthPeak22 NorthPeak22 7 minutes ago
My hope is that Trump issues an EO eliminating the need for an amended application by resetting the project back to before MARAD set this new standard. That would mean MARAD can simply issue the license and DOE can grant the extension as soon as Day 1. 
TGLO
100lbStriper 100lbStriper 8 minutes ago
no problem, we're good to go. only its on straps time when this conviens.
NLST
Hosai Hosai 8 minutes ago
The Dec update for CHMP figures gives in total for 2024 -

114 approvals
5 rejections
8 withdrawls.

That's an approval rate of 89.8% (114/127) if considering withdrawls as indirect rejections.

https://www.ema.europa.eu/en/news/meeting-highli
AVXL
nyt nyt 8 minutes ago
I just read that when you're

strummed like a banjo
and played like a fiddle,
you're one of those self styled, elite "true longs"
that have been left with very little...
VPLM
al44 al44 9 minutes ago
Hey Gmenfan-

It just goes to show how much liberals understand simple economics.

..............al
3331 3331 9 minutes ago
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
Whalatane Whalatane 10 minutes ago
RMB. Well apparently theres a last minute push to get the Kidney Patient Act attached to some end of year funding bill . Next wk is the last wk of 2024 to act apparently. .
Passage would probably be a big boost to ARDX and UNCY as passage this yr seems a long shot and I think largely priced
ARDX UNCY
3331 3331 10 minutes ago
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
rooster rooster 11 minutes ago
No that was what happened after a democrat was in charge it’s usually the republicans who come in and clean that mess up. Just sit back and enjoy the best economy we’re about to have under Trump
Konaploinks Konaploinks 12 minutes ago
I wonder if we’ll get any news on our fireside chat with General Dynamics yesterday. Any contract or partnership with them would be super huge. I think we’d all be eating a 40.00 cheese burger. I like mine Big Island organic grass fed beef on a grilled sesame seed bun buttered with garlic butter, wi
IONQ
Chartmaster Chartmaster 12 minutes ago
This weeks volume is huge!!! and very telling! .0026 target by the new year, then .02-.10 by March imo
AXXA
surfkast surfkast 12 minutes ago
Soon?
Subpoenas issued by Federal Regulatory and Law Enforcement Agencies
In most instances, iHub will comply with lawfully issued U.S. and state government subpoenas to the extent that they are not unduly burdensome or unreasonably invasive of our members' privacy. The subpoena should
HMBL
hockeypond hockeypond 12 minutes ago
A LAES poster was informing people on one of my crypto hold and decided to take a look at this....could have bought in the .50's when I frist saw it, but as all is aware you need to be cautious with people posting other plays....I do like the technology and the low share count of 32m and even though
LAES
arizona1 arizona1 13 minutes ago
Pro business period get them going and everything else will follow obviously you have no clue

Every single "pro business republican" gave us a recession which the democrats then had to come in and clean up. Read a damn history book!
europa7 europa7 13 minutes ago
SEALSQ...exclusive video posted by CEO Carlos Creus Moreira...

Carlos Creus Moreira
@CreusMoreira
Dec 12, 2024
***
"...We're proud to unveil an exclusive video showcasing @SEALSQcorp $LAES #PostQuantum #semiconductors being rigorously tested to defend agai
LAES

Your Recent History

EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved